secwatch / observer
8-K filed March 2, 2023, 6:59 PM ET ticker MCS CIK 0000062234
earnings confidence high sentiment neutral materiality 0.75

Marcus Corp reports Q4 loss, full-year revenue up 48%; Hotels record Adj. EBITDA

MARCUS CORP

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MARCUS CORP reported Fourth Quarter Fiscal 2022 results: revenue $162.9 million, net income ($9.3 million), EPS ($0.30).

Period
Fourth Quarter Fiscal 2022
Revenue
$162.9 million
Net income
($9.3 million)
EPS
($0.30)
Result
reported results
Exact text from the filing
Total revenues for the fourth quarter of fiscal 2022 were $162.9 million, a 3.6% decrease from total revenues of $169.0 million for the fourth quarter of fiscal 2021. • Operating loss was $2.7 million for the fourth quarter of fiscal 2022, compared to operating income of $14.0 million for the prior year quarter. • Net loss attributable to The Marcus Corporation was $9.3 million for the fourth quarter of fiscal 2022, compared to net earnings attributable to The Marcus Corporation of $6.4 million for the same period in fiscal 2021. Net loss attributable to the Marcus Corporation for the fourth quarter of fiscal 2022 was negatively impacted by $6.7 million, or $0.21 per share, of income tax expense due to net increases in valuation allowances for deferred state income taxes. • Net loss per diluted common share attributable to The Marcus Corporation was $0.30 for the fourth quarter of fiscal 2022, compared to net earnings per diluted common share attributable to The Marcus Corporation of $
View on SEC.gov

Browse all earnings releases →

MARCUS CORP filing history →

Source: SEC EDGAR
accession 0000062234-23-000002
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.